Loading…
GoodRx Holdings, Inc. is projected to rise to $3.76 by 2027, a +27% move from its current price of $2.95. GDRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.88 | $2.95 | $3.03 | +0.05% |
| Jul 13 | $2.85 | $2.95 | $3.06 | +0.11% |
| Jul 14 | $2.83 | $2.95 | $3.09 | +0.16% |
| Jul 15 | $2.81 | $2.96 | $3.11 | +0.21% |
| Jul 16 | $2.80 | $2.96 | $3.13 | +0.27% |
| Jul 17 | $2.78 | $2.96 | $3.15 | +0.32% |
| Jul 18 | $2.77 | $2.96 | $3.16 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.77 | $2.96 | $3.16 | +0.37% |
| Week 2 | $2.71 | $2.97 | $3.26 | +0.75% |
| Week 3 | $2.66 | $2.98 | $3.35 | +1.12% |
| Week 4 | $2.62 | $2.99 | $3.42 | +1.50% |
| Week 5 | $2.59 | $3.01 | $3.49 | +1.88% |
| Week 6 | $2.56 | $3.02 | $3.55 | +2.26% |
| Week 7 | $2.54 | $3.03 | $3.61 | +2.64% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. The company provides healthcare products and solutions for dogs, cats, and other pets.
It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
GoodRx Holdings, Inc. (GDRX) is a healthcare stock with a current price of $3.06 and a market cap of $1.04B, ranking 2554 by market capitalization.
The price outlook is anchored by a 2026 average forecast of $3.06, with a range from $1.87 to $4.21, illustrating potential near-term volatility and upside around the current level.
Looking further out, the forecast shows a rising path: 2027 avg $3.98; 2028 avg $5.00; 2029 avg $5.68; 2030 avg $5.87; 2031 avg $6.27; 2032 avg $6.47; 2033 avg $7.24; 2034 avg $8.81; 2035 avg $9.62; 2040 avg $12.95; 2050 avg $29.48. These rising averages imply meaningful upside over the long term.
A major floor 35.3% below — a decisive break under it would weaken the trend.
The nearest floor, 13.2% below — buyers have tended to step in here.
The nearest ceiling, 4.4% above — a clean break opens room to run.
A major ceiling 14.7% above — clearing it would confirm fresh momentum.
Key GDRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GDRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.99 | Sell | $2.96 | Sell |
| MA 10 | $2.96 | Sell | $2.93 | Buy |
| MA 20 | $2.82 | Buy | $2.86 | Buy |
| MA 50 | $2.73 | Buy | $2.72 | Buy |
| MA 100 | $2.46 | Buy | $2.66 | Buy |
| MA 200 | $2.78 | Buy | $2.93 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.59 | Neutral |
| Stoch RSI (14) | 58.82 | Neutral |
| CCI (20) | 61.43 | Neutral |
| Williams %R (14) | -25.49 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 10.49 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 74.51 | Neutral |
| TRIX (15) | 0.38 | Buy |
| Awesome (5,34) | 0.19 | Buy |
| Ultimate (7,14,28) | 60.06 | Neutral |
| Momentum (10) | 0.26 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 2.96 | Sell |
| ADX (14) | 16.02 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bullish, with RSI14 at 70 indicating strong momentum.
Shorter-term moving averages show SMA50 at $2.65 and SMA200 at $2.82, suggesting near-term price dynamics around a few dollars per share. The price is playing between support at $2.52 and resistance at $3.08, with the 30-day price range between $2.52 and $3.72.
Annualized volatility is listed at 60%, highlighting elevated near-term price fluctuations that traders may price into risk assessments.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.87 | $2.95 | $4.00 | 0% | Neutral | |
| $3.01 | $3.76 | $4.94 | +27% | Bullish | |
| $3.70 | $4.73 | $6.44 | +60% | Bullish | |
| $4.09 | $5.34 | $7.47 | +81% | Bullish | |
| $4.18 | $5.56 | $7.96 | +89% | Bullish | |
| $4.48 | $6.07 | $8.85 | +106% | Bullish | |
| $4.54 | $6.24 | $9.28 | +112% | Bullish | |
| $4.99 | $6.96 | $10.50 | +136% | Bullish | |
| $5.99 | $8.47 | $12.99 | +187% | Bullish | |
| $6.39 | $9.16 | $14.24 | +211% | Bullish | |
| $8.29 | $12.62 | $20.78 | +328% | Bullish | |
| $16.71 | $28.19 | $50.56 | +856% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.87 | $2.95 | $3.60 | +0.00% |
| August 2026 | $2.58 | $3.03 | $3.67 | +2.85% |
| September 2026 | $2.61 | $3.10 | $3.78 | +2.07% |
| October 2026 | $2.72 | $3.24 | $3.99 | +4.75% |
| November 2026 | $2.73 | $3.27 | $4.05 | +0.73% |
| December 2026 | $2.66 | $3.20 | $4.00 | -2.02% |
Click any year to see its month-by-month GDRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GDRX price prediction for 2026 points to an average of $2.95 (low $1.87, high $4.00) — a potential gain of 0% on today's $2.95. Price action looks broadly range-bound.
In 2027, GDRX is projected to trade between $3.01 and $4.94, averaging $3.76 — a potential gain of +27% from today's $2.95. That is up +27% on the projected 2026 average. Buyers look set to stay in control over this stretch.
GoodRx Holdings, Inc.'s 2028 outlook centres on $4.73, within a $3.70 to $6.44 range. That is up +26% on the projected 2027 average. That marks a +60% change versus current levels. Momentum favours further upside here.
By 2029, GDRX could reach as high as $7.47, with a base case around $5.34 and support toward $4.09 — roughly +81% from $2.95. Buyers look set to stay in control over this stretch.
Expect GDRX to range from $4.18 to $7.96 through 2030. The $5.56 average target implies a +89% move from current prices. That is up +4% on the projected 2029 average. Momentum favours further upside here.
The GDRX price prediction for 2031 points to an average of $6.07 (low $4.48, high $8.85) — a potential gain of +106% on today's $2.95. Buyers look set to stay in control over this stretch.
In 2032, GDRX is projected to trade between $4.54 and $9.28, averaging $6.24 — a potential gain of +112% from today's $2.95. That is up +3% on the projected 2031 average. Momentum favours further upside here.
GoodRx Holdings, Inc.'s 2033 outlook centres on $6.96, within a $4.99 to $10.50 range. That is up +11% on the projected 2032 average. That marks a +136% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, GDRX could reach as high as $12.99, with a base case around $8.47 and support toward $5.99 — roughly +187% from $2.95. Momentum favours further upside here.
Expect GDRX to range from $6.39 to $14.24 through 2035. The $9.16 average target implies a +211% move from current prices. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The GDRX price prediction for 2040 points to an average of $12.62 (low $8.29, high $20.78) — a potential gain of +328% on today's $2.95. Momentum favours further upside here.
In 2050, GDRX is projected to trade between $16.71 and $50.56, averaging $28.19 — a potential gain of +856% from today's $2.95. That is up +123% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GDRX today (≈ 338.983051 GDRX) could be worth
$9,556.32
+$8,556.32 (+856%) by 2050 · US Dollar
Based on the average projected GDRX price of $28.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GDRXwould be worth at today's price.
$1,000 invested in GDRX on Jul 10, 2025 (≈ 204.081629 GDRX) would be worth
$602.04
-$397.96 (-39.8%) today · 0.60× · US Dollar
Based on a GDRX entry price of $4.9 vs. today's $2.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.05 | $967.21 | -3.3% |
| 1 month ago | $2.56 | $1,152.34 | +15.2% |
| 3 months ago | $2.19 | $1,347.03 | +34.7% |
| 6 months ago | $2.88 | $1,024.31 | +2.4% |
| 1 year ago | $4.9 | $602.04 | -39.8% |
| All time (5.0y) ago | $32 | $92.19 | -90.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GDRX forecast.
Our base-case forecast reaches $5.90 around 2031.
Implied market cap at $5.90: $617.8M
The multi-year forecast reveals a clear upward trajectory in average prices from 2026 through 2050. The 2026 avg is $3.06, then the path includes 2030 avg $5.87, 2040 avg $12.95, and 2050 avg $29.48, signaling substantial long-run upside.
Projected ROI progresses from 0% in 2026 to 30.2% in 2027, 63.4% in 2028, 85.6% in 2029, 91.8% in 2030, 104.8% in 2031, 111.6% in 2032, 136.5% in 2033, 187.9% in 2034, 214.4% in 2035, 323.2% in 2040, and 863.3% by 2050, with sentiment labeled BULLISH in the later years.
These figures reflect estimates of future price paths and investor sentiment over time. They are not guarantees and should be considered within the context of inherent market risk and uncertainty.
Tap a question to reveal the answer.
Avg $5.87; Min $4.29; Max $8.68; ROI 91.8%; sentiment BULLISH.
The forecast shows a bullish trajectory with rising averages and ROIs reaching up to 863.3% by 2050, but these are estimates and not guarantees.
Yes. The 2033 max is $11.37 and the 2034 max is $14.08, indicating that $10 could be surpassed by the mid-2030s per the forecast.
Current price is $3.06 and market cap is $1.04B.
30-day range is $2.52 to $3.72; RSI 14 is 70; SMA50 is $2.65; SMA200 is $2.82; support is $2.52 and resistance is $3.08; sentiment is BULLISH.
GoodRx Holdings, Inc. Community Discussion
0Share your GoodRx Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.